MYC and neoplasm: In mice, the tumour-protective benefit of germline Myc haploinsufficiency is accompanied by unwelcome side-effects, including small body size with variably reduced cellularity across organs26, infertility25 and a profound deficit in haematopoiesis due to aberrant self-renewal of haematopoietic stem cells39.